维普期刊资源整合服务平台（V6.5）

126篇 您的检索式：作者名="Venook"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival显示文摘	Francis Y. Yao Linda Ferrell Nathan M. Bass Jessica J. Watson Peter Bacchetti Alan Venook Nancy L. Ascher John P. Roberts	2001	Hepatology2001，，6：	5
2	Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design显示文摘	Matthew H. G. Katz Robert Marsh Joseph M. Herman Qian Shi Eric Collison Alan P. Venook Hedy L. Kindler Steven R. Alberts Philip Philip Andrew M. Lowy Peter W. T. Pisters Mitchell C. Posner Jordan D. Berlin Syed A. Ahmad	2013	Annals of Surgical Oncology2013，，8：	4
3	Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival显示文摘	Francis Y. Yao Linda Ferrell Nathan M. Bass Jessica J. Watson Peter Bacchetti Alan Venook Nancy L. Ascher John P. Roberts	2001	Hepatology2001，，6：	2
4	Phase Ⅲ study of irinotecan/5FU/LV (FOLFIRI)or oxaliplatin/5FU/LV (FOLFOX)-+-cetuximab for pa- tients with untreated metastatic adenocarcinoma ofthe colon or rectum (MCRC): CALGB 80203 pre- liminary results显示文摘	VENOOK A NIEDZWIECKI D HOLLIS D	2006	Journal of Clinical Oncology2006，24，18：	1
5	Critical evaluation of current treatments in metastatic colorectal cancer 显示文摘	Venook A	2005	Oncologist2005，10，4：	1
6	Targeted therapy in colorectal cancer 显示文摘	Rajpal S Venook AP	2006	Clin Adv Hematol Oncol2006，4，2：	1
7	Hepatocellular carcinoma: The role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy显示文摘	O'Nell BH Venook AP	2007	Oncologist2007，12，12：	1
8	A phase II study of fixed -dose rate gemcitabine plus low- dose cisplatin fol- lowed by consolidative chemoradiation for locally advanced pancreatic cancer显示文摘	KO AH QUIVEY JM VENOOK AP	2007	Int J Radiat Oncol Biol Phys2007，68，3：	1
9	NCCN Clinical Practice Guidelines in Oncology:rectal cancer 显示文摘	Engstrom PF Arnoletti JP Benson AB 3rd Chen YJ Choti MA Cooper HS Covey A Dilawari RA Early DS Enzinger PC Fakih MG Fleshman J Jr Fuchs C Greta JL Kiel K Knol JA Leong LA Lin E Mulcahy MF Rao S Ryan DP Saltz L Shibata D Skibber JM Sofocleous C Thomas J Venook AP Willett C	2009	J Natl Compr Canc Netw2009，7，：	1
10	Prepolarized mag- netic resonance imaging around metal orthopedic implants显示文摘	Venook RD Matter NI Ramachandran M	2006	Magn Reson Med2006，56，1：	1
11	Hepatocellular carcinoma:the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy显示文摘	O'Neil BH Venook AP	2007	Oncologist2007，12，12：	1
12	CALGB/SWOG 80405:phase Ⅲ trial of irinotecart/5-FU/leucovorin (FOLFIRI)or oxaliplatin/5-FU/qeucovorin (mFOLFOX6) with bevacizumab (RV)or cetuximab(CET)for patients (pts)with KRAS wild-type(wt)untreated metastatic ade- nocarcinoma of the colon or rectum (MCRC) 显示文摘	Venook AP Niedzwiecki D Lenz H	2014	J Clin Oncol2014，32，15：	1
13	Alternating hepatic intra arterial floxuridine and flouorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer 显示文摘	Stagg RJ Venook AP Chase JL	1991	J Natl Cancer Inst1991，83，：	1
14	Phase Ⅲ study of irinotecan/ 5-FU/ LV (FOLFIRI) or oxaliplatin/ 5-FU/ LV (FOLFOX) + cetuximab for patients ( pts ) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC) : CALGB 80203 preliminary results 显示文摘	VENOOK A NIEDZWIECKI D HOLLIS D	2006	J Clin Oncol2006，24，18：	1
15	The incidence and epidemiology of hepatoceUular carcinoma: a global and regional perspective显示文摘	Venook AP Papandreou C Furuse J	2010	Oncologist2010，15，4：	1
16	The incidence andepidemiology of hepatocellular carcinoma: a global and regionalperspective显示文摘	Venook AP Papandreou C Furuse J	2010	Oncologist2010，154，：	1
17	Sorafenib in hepatocellular carcinoma:separating the hype from the hope显示文摘	Kelley RK Venook AP	2008	J Clin Oncol2008，26，36：	1
18	Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer 显示文摘	Ko AH Hwang J Venook AP	2005	Br J Cancer2005，93，2：	1
19	Phase Ⅰ and pharmacokinetics trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565显示文摘	Egorin MJ Rosner GL	2000	J Clin Oncol2000，18，14：	1
20	Shedding of paradigms:developing virus to treat cancer显示文摘	Bergsland E K Venook A P	2002	J Clin Oncol2002，20，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示